Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Deutsch

Showing results (11-20 of 244) with videos related to

Pageof 25
Sort By:
Current Topics in Behavioral Neurosciences|May 30, 2020
An Evolving Therapeutic Rationale for Targeting the α<sub>7</sub> Nicotinic Acetylcholine Receptor in Autism Spectrum DisorderStephen I Deutsch, Jessica A Burket
Clinical Neuropharmacology|November 1, 2002
Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophreniaRichard B Rosse, Stephen I Deutsch
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2018
Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorderJessica A Burket, Stephen I Deutsch
Hospital & Community Psychiatry|May 1, 1983
Schizophrenia: a review of diagnostic and biological issues. II. Biological issuesS I Deutsch, K L Davis
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1991
[The knowledge and attitudes of medical students in their 2d year about AIDS]I Deutsch, M Blujdescu, C Cernescu
Optics Express|April 30, 2009
Spatial correlation diagnostics for atoms in optical latticesJ Grondalski, P Alsing, I Deutsch
Hospital & Community Psychiatry|April 1, 1983
Schizophrenia: a review of diagnostic and biological issues. I. Diagnosis and prognosisS I Deutsch, K L Davis
The Medical Clinics of North America|November 19, 2022
From Mouse to Man: N-Methyl-d-Aspartic Acid Receptor Activation as a Promising Pharmacotherapeutic Strategy for Autism Spectrum DisordersStephen I Deutsch, Jessica A Burket
Clinical Neuropharmacology|February 1, 1988
Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamateS I Deutsch, J M Morihisa
Clinical Neuropharmacology|April 26, 2021
A De Novo Missense Variant of SCN2A: Implications and Limitations for Understanding Clinical Phenotype and Treatment RecommendationsStephen I Deutsch, Jessica A Burket
Pageof 25

Showing results (11-20 of 244) with videos related to

Sort By:
Pageof 25
Current Topics in Behavioral Neurosciences|May 30, 2020
An Evolving Therapeutic Rationale for Targeting the α<sub>7</sub> Nicotinic Acetylcholine Receptor in Autism Spectrum DisorderStephen I Deutsch, Jessica A Burket
Clinical Neuropharmacology|November 1, 2002
Adjuvant galantamine administration improves negative symptoms in a patient with treatment-refractory schizophreniaRichard B Rosse, Stephen I Deutsch
Progress in Neuro-Psychopharmacology & Biological Psychiatry|November 28, 2018
Metabotropic functions of the NMDA receptor and an evolving rationale for exploring NR2A-selective positive allosteric modulators for the treatment of autism spectrum disorderJessica A Burket, Stephen I Deutsch
Hospital & Community Psychiatry|May 1, 1983
Schizophrenia: a review of diagnostic and biological issues. II. Biological issuesS I Deutsch, K L Davis
Revue Roumaine De Virologie (Bucharest, Romania : 1990)|July 1, 1991
[The knowledge and attitudes of medical students in their 2d year about AIDS]I Deutsch, M Blujdescu, C Cernescu
Optics Express|April 30, 2009
Spatial correlation diagnostics for atoms in optical latticesJ Grondalski, P Alsing, I Deutsch
Hospital & Community Psychiatry|April 1, 1983
Schizophrenia: a review of diagnostic and biological issues. I. Diagnosis and prognosisS I Deutsch, K L Davis
The Medical Clinics of North America|November 19, 2022
From Mouse to Man: N-Methyl-d-Aspartic Acid Receptor Activation as a Promising Pharmacotherapeutic Strategy for Autism Spectrum DisordersStephen I Deutsch, Jessica A Burket
Clinical Neuropharmacology|February 1, 1988
Glutamatergic abnormalities in Alzheimer's disease and a rationale for clinical trials with L-glutamateS I Deutsch, J M Morihisa
Clinical Neuropharmacology|April 26, 2021
A De Novo Missense Variant of SCN2A: Implications and Limitations for Understanding Clinical Phenotype and Treatment RecommendationsStephen I Deutsch, Jessica A Burket
Pageof 25